What is the recommended management for symptomatic bradycardia in pediatric patients?

Management of Symptomatic Bradycardia in Pediatric Patients

Oxygenation and ventilation are the essential first maneuvers for symptomatic bradycardia in children, followed by chest compressions if the heart rate remains <60 bpm with signs of poor perfusion despite adequate ventilation, and epinephrine is the drug of choice if these measures fail. 1, 2

Algorithmic Approach to Management

Step 1: Immediate Assessment and Oxygenation

• Ensure adequate oxygenation and ventilation FIRST - this is the most critical intervention as hypoxia is the most common cause of pediatric bradycardia 1
• Look for signs of poor perfusion: pallor, mottling, cyanosis, altered mental status, hypotension 3
• Determine if bradycardia is causing the symptoms or is a manifestation of another process (hypoxia, hypothermia, increased vagal tone, medications, electrolyte abnormalities) 4

Step 2: Initiate CPR if Indicated

Begin chest compressions if:

• Heart rate <60 bpm AND
• Signs of poor perfusion persist DESPITE adequate oxygenation and ventilation 2, 3

This threshold is based on the principle that cardiac output in children depends heavily on heart rate, and profound bradycardia with poor perfusion indicates imminent cardiac arrest. Starting CPR before full arrest improves survival - studies show patients receiving CPR for bradycardia with poor perfusion have better outcomes than those who progress to asystole 2, 5

Step 3: Pharmacologic Management

First-line drug: Epinephrine

• Epinephrine is the drug of choice if oxygen and adequate ventilation are not effective 1
• Dose: IV/IO: Standard dose per PALS guidelines
• ET route: Neonates 0.01-0.03 mg/kg; Children/adolescents 0.03-0.06 mg/kg 1

Second-line drug: Atropine (specific indications only)

• Use atropine for:

  • Symptomatic vagally mediated bradycardia or AV block 1
  • Symptomatic bradycardia unresponsive to oxygenation, ventilation, AND epinephrine 1
  • Anticholinesterase poisoning 1

• Atropine dosing:

  • IV/IO: 0.02 mg/kg
  • Minimum single dose: 0.1 mg (to avoid paradoxical bradycardia)
  • Maximum single dose: 0.5 mg (child), 1.0 mg (adolescent)
  • May repeat every 5 minutes to maximum total: 1 mg (child), 2 mg (adolescent) 1

Critical caveat: The 2020 and 2025 ILCOR guidelines emphasize there is insufficient evidence to support routine use of atropine for pediatric cardiac arrest 2, 5. Atropine is reasonable for specific vagally-mediated bradycardia but should not delay epinephrine administration.

Step 4: Transcutaneous Pacing (Selected Cases Only)

• Consider for: Complete heart block or sinus node dysfunction in selected cases 2
• NOT helpful for: Bradycardia secondary to hypoxic/ischemic injury or respiratory failure 2
• NOT recommended for: Asystolic cardiac arrest 6
• Pacing is painful in conscious patients and requires sedation 4

Common Pitfalls to Avoid

1. Giving atropine before ensuring adequate oxygenation and ventilation - this reverses the proper sequence and delays the most effective intervention 1

2. Using atropine doses <0.1 mg - can cause paradoxical bradycardia through vagal stimulation 1, 7

3. Delaying chest compressions in a child with HR <60 bpm and poor perfusion who is adequately oxygenated and ventilated - progression to pulselessness worsens outcomes 2, 5

4. Confusing atropine concentrations - atropine comes in different concentrations; calculate dosage accordingly 1

5. Using transcutaneous pacing for hypoxia-induced bradycardia - pacing is ineffective when the underlying cause is hypoxic/ischemic injury 2

6. Undertreating prehospital pediatric bradycardia - a 2023 study found variable adherence to PALS guidelines in the prehospital setting, with many children not receiving recommended interventions 8

Evidence Strength and Nuances

The strongest evidence comes from the 2020 and 2025 ILCOR Pediatric Life Support guidelines 2, 5, which represent international consensus. These guidelines consistently emphasize:

• Oxygenation/ventilation as the primary intervention (unchanged since 2010)
• Epinephrine as the preferred drug when ventilation fails
• Limited role for atropine - only for specific vagally-mediated causes

The 2008 Pediatrics guidelines 1 provide detailed dosing information that remains current, though the treatment hierarchy has been refined in subsequent updates.

Important limitation: The 2025 ILCOR review 5 identified significant gaps in the literature, including absence of studies comparing CPR versus no CPR for bradycardia with hemodynamic compromise, and lack of data on optimal timing for intervention initiation. However, indirect evidence strongly supports early CPR initiation based on improved survival when CPR is started during bradycardia versus after progression to pulselessness.